Cardiac Implant Market Insights
Cardiac implants are designed to monitor irregular heartbeats in people suffering from heart rhythm disorders. These abnormalities are caused by problems with the heart’s electrical system, which signals the heart to contract and pump blood throughout the body. Cardiac implant devices include pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy, implantable hemodynamic monitoring, and implanted heart rhythm monitors that are also known as loop recorders. These implants are used for treating myocardial ischemia, arrhythmias, and acute myocardial infraction. Aging population and demographic changes across the world are expected to increase prevalence of heart disease, which in turn, is expected to increase demand for cardiac implants over the forecast period. According to the American College of Cardiology, as of 2017, cardiovascular diseases account for around 800,000 deaths in the U.S, and it remains the leading cause of death in the country.
The global cardiac implant market was valued at US$ 34,783.4 million in 2018, and is expected to witness a CAGR of 11.6% during the forecast period (2019–2026).
Figure 1. Global Cardiac Implant Market value Analysis (US$ Mn), By Device
Source: Coherent Market Insights Analysis (2019)
Increasing regulatory approval for cardiac implants is expected to drive growth of the global cardiac implant market
Most of the hospitals and healthcare organizations indicates cardiovascular implants in patients at risk of cardiac disorder, in order to provide artificial control on the patient’s heart beat in the long term. Increasing number of regulatory approvals for innovative and advanced cardiac implant devices is expected to facilitate growth of the cardiac market in the near future. For instance, in February 2017, Abbott received the U.S. Food and Drug Administration approval for its Assurity MRI pacemaker, which is the smallest, long-lasting wireless MRI-compatible pacemaker. Patients implanted with Assurity MRI pacemaker can undergo full body magnetic resonance imaging (MRI) scans, if required.
Moreover, rising incidence of cardiovascular diseases around the world is expected to boost growth of the cardiac implant market over the forecast period. According to the World Health Organization, in 2015, around 17.7 million deaths were caused by cardiovascular diseases, out of which around 7.4 million deaths were caused due to coronary heart disease, and 6.7 million deaths due to stroke.
Cardiac Implant Market- Restraints
Infections associated with implantable pacemakers in cardiac patients is likely to dissuade patients from opting for these products, which may restrain demand for cardiac implants. For instance, according to Medtronic Plc, risks associated with an implantable cardioverter defibrillators (ICD) implant include surgical site infections, sensitivity to the device material, failure to deliver therapy when it is needed, and receiving extra therapy when it is not needed. Moreover, after receiving an ICD therapy, patient will have limitations with respect to electromagnetic and magnetic radiation.
Cardiac Implant Market- Regional Analysis
Regional segmentation of the global cardiac implant market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold a dominant position in the market, owing to rising demand for pacemakers. According to the American Heart Association (AHA), 2017, around 92.1 million adults in the U.S. are suffering from some form of cardiovascular disease, or after-effects of stroke. The AHA report also stated that direct and indirect costs of cardiovascular diseases and stroke are estimated to account for US$ 316 billion, including health expenditures and lost productivity.
The Asia Pacific cardiac implant market is expected to witness significant growth during the forecast period owing to increasing preference for technologically advanced products for cardiac rhythm management, coupled with rising healthcare concerns for stroke prevention associated with atrial fibrillation. According to the Japanese Heart Rhythm Society, in 2017, the Asian population with atrial fibrillation (AF) is estimated to reach 72 million by 2050, of which 2.9 million may suffer from AF-associated strokes.
Europe is expected to show significant growth rate, owing to rising number of approvals by the European Drug regulatory authorities for cardiac implants for various purposes. For instance, in 2015, EBR Systems received the CE marking for its WiSE leadless pacemaker. The device is intended to improve the left ventricular function. Moreover, in February 2017, Medtronic Plc. received the CE marking for a suite of quadripolar cardiac resynchronization therapy pacemakers (CRT-Ps) that also allow patients to receive MRI (magnetic resonance imaging) scans.
Figure 2: Global Cardiac Implant Market Value (US$ Mn), By Region
Source: Coherent Market Insights Analysis (2019)
Cardiac Implant Market - Competitive Landscape
Key players operating in the global cardiac implant market include Medtronic Plc. BIOTRONIK, Inc., Boston Scientific Corporation, Abbott Laboratories, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC, and Qinming Medical, and Cordis Inc.
Cardiac implants are devices that are implanted in the heart tissue, in order to control irregular heart function. Cardiac implants such as pacemakers, defibrillator implants, and cardiac rhythm monitoring implants are available in the market to treat cardiac dysfunction such as heart rhythm disorders, arrhythmias and other heart related disorder. These cardiac implants are majorly prescribed to patients with heart failure. Cardiac implants have been developed with innovative technical features in recent years which has improved quality of life in patients with heart failure. For instance, technologically advanced cardiac implants such as HeartWare HVAD Pump (HeartWare), Parachute Ventricular Partitioning Device (CardioKinetix Inc.), and Quadra Assura MP (St. Jude Medical, Inc.) are currently available in the market. Thus, technological advancements in implantable cardiac devices is propelling the cardiac implant market growth.
Increasing focus of manufacturers on development and introduction of highly advanced implantable devices aimed at improving patient outcome, is expected to drive growth of the cardiac implant market. For instance, in April 2016, St. Jude Medical, Inc. launched the Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D) in the U.S market. The company was later acquired by Abbott in January 2017.
Moreover, regulatory approvals for cardiac implantable devices is expected to drive growth of the cardiac implant market. For instance, in April 2016, the U.S. Food and Drug Administration approved the first pacemaker, Micra Transcatheter Pacing System, developed by Medtronic Plc Plc. The system does not require wired leads to establish an electric connection between the pulse-generating device and the heart. The device functions like a pacemaker to regulate heart rate. The device is implanted directly in the right ventricle chamber of the heart.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 32 market data tables and 30 figures on "Cardiac Implant Market” - Global forecast to 2026”.
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.